Li Shanto Pharmaceuticals Private Limited

Li Shanto Pharmaceuticals Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
CIN U24304PN2020PTC193291 Incorporated 24 August 2020 ROC Pune HQ Pune, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹1.53 Cr
▼ 22% YoY
Net profit · FY 2024
₹91,355
Net margin 0.6%
EBITDA · FY 2024
₹6.45 Lakh
EBITDA margin 4.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
4
As per MCA filings

About Li Shanto Pharmaceuticals Private Limited

Data last updated:

Li Shanto Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 August 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24304PN2020PTC193291. Its GSTIN is 20AAECL3091K1ZN (Jharkhand).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Birendra Kumar Singh (Managing Director) and Akash Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S. No. 5/4 F. No. 604B Tara Angan Keshav Nagar Pune Maharastra – 411036, Maharashtra, India – 411036.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.53 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹91,355 (net margin 0.6%) and EBITDA of ₹6.45 Lakh (EBITDA margin 4.2%).

As per MCA filings, the company has open charges of ₹50 Lakh on record.

Li Shanto Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0162169).

Company details

CIN U24304PN2020PTC193291
Registration Number 193291
Incorporation Date 24 August 2020
ROC Pune
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0162169

Recognitions & Rankings of Li Shanto Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-26-0162169

Contact details

Li Shanto Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    S. No. 5/4 F. No. 604B Tara Angan Keshav Nagar Pune Maharastra – 411036, Maharashtra, India – 411036
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Li Shanto Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Li Shanto Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Li Shanto Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Li Shanto Pharmaceuticals Private Limited, buy the company report.

Financials of Li Shanto Pharmaceuticals Private Limited

FY 2025 filings available

Li Shanto Pharmaceuticals Private Limited reported revenue of ₹1.53 Cr (down 22% YoY) for FY 2024.

Revenue · FY 2024
₹1.53 Cr ▼ 22%
Net profit · FY 2024
₹91,355 margin 0.6%
EBITDA · FY 2024
₹6.45 Lakh margin 4.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 22%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 300%

Revenue fell 22% in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.45 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹91,355
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.2%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Li Shanto Pharmaceuticals Private Limited, buy the company report.

Board of directors of Li Shanto Pharmaceuticals Private Limited

Li Shanto Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Akash KumarDirector24 Aug 20206 Years 2 MonthsCurrent
Vikash Kumar SinghDirector24 Aug 20206 Years 2 MonthsCurrent
Birendra Kumar SinghManaging Director24 Aug 20206 Years 2 MonthsCurrent
Sanjeev KumarDirector24 Aug 20206 Years 2 MonthsCurrent

Peer comparison

Li Shanto Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Kript Pharmaceuticals Private Limited₹1.54 Cr (FY 2025)-19.0%Kurukshetra, Haryana, India
Li Shanto Pharmaceuticals Private Limitedthis company₹1.53 Cr (FY 2024)₹91,3550.6%-22.0%Pune, Maharashtra, India
Shree Vishwamitra Ayurved Pharmaceuticals Private Limited₹1.53 Cr (FY 2025)10.0%Ahmedabad, Gujarat, India
Sahana Pharmaceuticals Private Limited₹1.52 Cr (FY 2025)41.0%Nagercoil, Tamil Nadu, India

To see the full peer comparison of Li Shanto Pharmaceuticals Private Limited, buy the company report.

Auditor

Li Shanto Pharmaceuticals Private Limited is audited by D. K. Verma & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
D. K. Verma & AssociatesFY 2023326227E

Shareholding

The shareholding of Li Shanto Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Li Shanto Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Canara Bank₹0.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
01 Feb 2022100557479Canara Bank₹50 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Li Shanto Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Li Shanto Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 12, 2026.

Active EPFO establishments
1

GST

Li Shanto Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
20AAECL3091K1ZNJharkhandActive28 May 2021

To see the full GST registrations and return filing status of Li Shanto Pharmaceuticals Private Limited, buy the company report.

Recent activity

Li Shanto Pharmaceuticals Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Akash Kumar was appointed as Director on 24 Aug 2020.

AGM
Li Shanto Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Li Shanto Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Charges
A charge with Canara Bank amounted to Rs. 50.00 Lakh with Charge ID 100557479 was registered on 01 Feb 2022.
Appointed
Akash Kumar was appointed as Director.
Appointed
Birendra Kumar Singh was appointed as Managing Director.
Appointed
Sanjeev Kumar was appointed as Director.
Appointed
Vikash Kumar Singh was appointed as Director.
Incorporation
24 Aug 2020
Li Shanto Pharmaceuticals Private Limited was registered on 24 Aug 2020 with Roc Pune & aged 6 years 3 months as per MCA records.

Frequently asked questions

Li Shanto Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 August 2020 (6+ years old) and is registered under CIN U24304PN2020PTC193291.

Li Shanto Pharmaceuticals has 4 current directors:

The latest financial statements of Li Shanto Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Li Shanto Pharmaceuticals is 20AAECL3091K1ZN, registered in Jharkhand.

The CIN (Corporate Identification Number) of Li Shanto Pharmaceuticals is U24304PN2020PTC193291. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Li Shanto Pharmaceuticals was incorporated on 24 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.

The peers of Li Shanto Pharmaceuticals by revenue are Kript Pharmaceuticals Private Limited, Shree Vishwamitra Ayurved Pharmaceuticals Private Limited, Sahana Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Akash Kumar was appointed as Director on 24 Aug 2020. Birendra Kumar Singh was appointed as Managing Director on 24 Aug 2020. Sanjeev Kumar was appointed as Director on 24 Aug 2020. Li Shanto Pharmaceuticals has 4 board changes on record in total.

Yes, Li Shanto Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0162169).

The registered office of Li Shanto Pharmaceuticals is at S. No. 54 F. No. 604B Tara Angan Keshav Nagar Pune Maharastra – 411036, Maharashtra, India – 411036.

Li Shanto Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.